Skip to content


  • Invited speaker presentation
  • Open Access

Discussion session: biomarker trials

Trials201516 (Suppl 2) :I2

  • Published:


  • Public Health
  • Trial Design
  • Discussion Session
  • Combine Presentation

Various speakers In a combined presentation and discussion session, representatives from academia and industry discuss the role of Biomarker trial design and implementation, to improve health by improving trials.



By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.